Santori & Peters, Inc. Gilead Sciences, Inc. Transaction History

Santori & Peters, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 28, 2021	SELL	$60.0 - $68.46 $514,080 - $586,565	-8,568 Closed	0 $0
Q4 2020 Jan 13, 2021	BUY	$56.65 - $64.55 $485,377 - $553,064	8,568 New	8,568 $540,000
Q2 2020 Jul 07, 2020	SELL	$72.34 - $84.0 $465,073 - $540,036	-6,429 Closed	0 $0
Q1 2020 Apr 27, 2020	BUY	$62.63 - $80.22 $402,648 - $515,734	6,429 New	6,429 $480,000
Q1 2018 Apr 16, 2018	SELL	$72.84 - $88.8 $24,401 - $29,748	-335 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $23,835 - $27,979	335	335 $26,000

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Santori & Peters, Inc., based on Form 13F filings with the SEC.

Stay updated on Santori & Peters, Inc. with notifications on news.